Related Experiment Video
Updated: Jun 2, 2026
Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Macrophage inflammatory protein (mip)-1-alpha stem-cell inhibitor (sci) does not affect clonal growth of human solid
A Korfel1, Z Vonmarschall, M Koenigsmann
1FREE UNIV BERLIN,KLINIKUM STEGLITZ,DEPT HEMATOL & ONCOL,HINDENBURGDAMM 30,D-12200 BERLIN,GERMANY.
Abstract:
MIP-1alpha is a member of a family of proinflammatory cytokines produced by activated macrophages which has been shown to be a negative regulator of early hematopoietic stem cell progenitors. We report on results testing recombinant human (rh) MIP-1alpha on the clonal growth of different human nonhematopoietic tumor cell lines in vitro. Cell lines tested included the following histologies: 7 glioblastomas, 1 neuroblastoma, 2 head and neck carcinomas, 4 lung carcinomas, 3 colorectal carcinomas, 1 gastric carcinoma, 1 pancreatic carcinoma, 1 breast carcinoma, 1 prostate carcinoma, 1 choriocarcinoma, 1 ovary carcinoma, 1 osteosarcoma, and 3 melanomas. MIP-1alpha (0, 2, 20, 200 ng/ml) was tested in human tumor cloning assays (HTCA) in agar-containing capillaries (HTCAcap) and in mixtures of methylcellulose and agar (HTCAmix), representing assay systems with different plating efficiencies (PE). Tumor cells were continuously exposed to the cytokine for the complete assay period. Clonal growth of none of the cell lines was significantly and reproducibly stimulated or inhibited by MIP-1alpha.
Insights
Recombinant human MIP-1alpha did not significantly affect the clonal growth of various human nonhematopoietic tumor cell lines in vitro. This study investigated the cytokine
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Macrophage-produced proinflammatory cytokines, such as MIP-1alpha, regulate hematopoietic stem cell progenitors.
- The role of MIP-1alpha in nonhematopoietic tumor cell growth is not well understood.
Purpose of the Study:
- To evaluate the effect of recombinant human MIP-1alpha on the in vitro clonal growth of diverse human nonhematopoietic tumor cell lines.
- To determine if MIP-1alpha acts as a modulator of tumor cell proliferation.
Main Methods:
- Human tumor cloning assays (HTCA) were performed using agar-containing capillaries (HTCAcap) and methylcellulose-agar mixtures (HTCAmix).
- Various human tumor cell lines (glioblastomas, carcinomas, melanomas, etc.) were exposed to different concentrations of recombinant human MIP-1alpha (0-200 ng/ml).
- Continuous exposure to MIP-1alpha throughout the assay period assessed its impact on clonal growth.
Main Results:
- Recombinant human MIP-1alpha did not demonstrate significant or reproducible stimulation or inhibition of clonal growth across any of the tested tumor cell lines.
- The effects of MIP-1alpha were consistent across different assay systems (HTCAcap and HTCAmix) with varying plating efficiencies.
Conclusions:
- MIP-1alpha does not appear to directly influence the in vitro clonal proliferation of the investigated human nonhematopoietic tumor cell lines.
- Further research may be needed to explore potential indirect roles or effects in different biological contexts.
